Skip to main content

01.04.2013

p53 Contributes to Quercetin-Induced Apoptosis in Human Rheumatoid Arthritis Fibroblast-like Synoviocytes

Erschienen in: Inflammation | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

In the present study, we sought to explore the mechanism of quercetin-induced apoptosis in rheumatoid arthritis fibroblast-like synoviocytes (RAFLSs). DNA fragmentation assay was used to detect quercetin-induced apoptosis in RAFLSs. The cleavages of caspase-3 and caspase-9 and the accumulation of cytosolic cytochrome C were measured by western blot in quercetin-treated RAFLSs. Mitochondrial membrane potential was tested by flow cytometry. Small interfering RNAs were used to knock down the expression of protein 53 (p53) and analyze the role of p53 in quercetin-induced apoptosis in RAFLSs. DNA fragmentation assay showed that quercetin dose-dependently elevated the apoptosis of RAFLSs, accompanying with enhanced caspase-3 and caspase-9 cleavages. Moreover, quercetin caused a concentration-dependent loss of mitochondrial membrane potential and cytochrome c release to cytosol and also decreased Bcl-2/Bax ratio, indicating that quercetin-induced apoptosis is through mitochondrial pathway. Quercetin also elevated p53 phosphorylation at ser15. Pretreatment with pifithrin-α, a p53 inhibitor, significantly diminished p53 phosphorylation at the concentration of 30 μM and abrogated quercetin-induced apoptosis in a dose-dependent manner. Quercetin-induced apoptosis was also significantly blocked by p53 silencing, further suggesting the involvement of p53 in quercetin-induced apoptosis in RAFLSs. Our study indicated that quercetin-induced apoptosis of RAFLSs is through mitochondrial pathway, in which p53 plays an important role.
Literatur
1.
Zurück zum Zitat Harris Jr., E.D., and Rheumatoid arthritis. 1990. Pathophysiology and implications for therapy. The New England Journal of Medicine 322: 1277–1289.PubMedCrossRef Harris Jr., E.D., and Rheumatoid arthritis. 1990. Pathophysiology and implications for therapy. The New England Journal of Medicine 322: 1277–1289.PubMedCrossRef
2.
Zurück zum Zitat Tran, C.N., S.K. Lundy, and D.A. Fox. 2005. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 12: 183–189.PubMedCrossRef Tran, C.N., S.K. Lundy, and D.A. Fox. 2005. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 12: 183–189.PubMedCrossRef
3.
Zurück zum Zitat Firestein, G.S. 2005. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. Journal of Clinical Rheumatology 11: S39–S44.PubMedCrossRef Firestein, G.S. 2005. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. Journal of Clinical Rheumatology 11: S39–S44.PubMedCrossRef
4.
Zurück zum Zitat Gay, S., R.E. Gay, and W.J. Koopman. 1993. Molecular and cellular mechanisms or joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Annals of the Rheumatic Diseases 52: S39–S47.PubMedCrossRef Gay, S., R.E. Gay, and W.J. Koopman. 1993. Molecular and cellular mechanisms or joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Annals of the Rheumatic Diseases 52: S39–S47.PubMedCrossRef
5.
Zurück zum Zitat Huber, L.C., O. Distler, I. Tamer, R.E. Gay, S. Gay, and T. Pap. 2006. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology 45: 669–675.PubMedCrossRef Huber, L.C., O. Distler, I. Tamer, R.E. Gay, S. Gay, and T. Pap. 2006. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology 45: 669–675.PubMedCrossRef
6.
Zurück zum Zitat Pattacini, L., L. Boiardi, B. Casali, and C. Salvarani. 2010. Differential effects of anti-TNF-alpha drugs on fibroblast-like synoviocyte apoptosis. Rheumatology (Oxford, England) 49: 480–489.CrossRef Pattacini, L., L. Boiardi, B. Casali, and C. Salvarani. 2010. Differential effects of anti-TNF-alpha drugs on fibroblast-like synoviocyte apoptosis. Rheumatology (Oxford, England) 49: 480–489.CrossRef
7.
Zurück zum Zitat Miyashita, T., A. Kawakami, M. Tamai, Y. Izumi, H. Mingguo, F. Tanaka, S. Abiru, K. Nakashima, N. Iwanaga, K. Aratake, M. Kamachi, K. Arima, H. Ida, K. Migita, T. Origuchi, S. Tagashira, F. Nishikaku, and K. Eguchi. 2003. Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells. Biochemical and Biophysical Research Communications 312: 397–404.PubMedCrossRef Miyashita, T., A. Kawakami, M. Tamai, Y. Izumi, H. Mingguo, F. Tanaka, S. Abiru, K. Nakashima, N. Iwanaga, K. Aratake, M. Kamachi, K. Arima, H. Ida, K. Migita, T. Origuchi, S. Tagashira, F. Nishikaku, and K. Eguchi. 2003. Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells. Biochemical and Biophysical Research Communications 312: 397–404.PubMedCrossRef
8.
Zurück zum Zitat Palao, G., B. Santiago, M. Galindo, M. Pallá, J.C. Ramírez, and J.L. Pablos. 2004. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis and Rheumatism 50: 2803–2810.PubMedCrossRef Palao, G., B. Santiago, M. Galindo, M. Pallá, J.C. Ramírez, and J.L. Pablos. 2004. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis and Rheumatism 50: 2803–2810.PubMedCrossRef
9.
Zurück zum Zitat Aupperle, K.R., D.L. Boyle, M. Hendrix, E.A. Seftor, N.J. Zvaifler, M. Barbosa, and G.S. Firestein. 1998. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. The American Journal of Pathology 152: 1091–1098.PubMed Aupperle, K.R., D.L. Boyle, M. Hendrix, E.A. Seftor, N.J. Zvaifler, M. Barbosa, and G.S. Firestein. 1998. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. The American Journal of Pathology 152: 1091–1098.PubMed
10.
Zurück zum Zitat Chou, C.T., J.S. Yang, and M.R. Lee. 2001. Apoptosis in rheumatoid arthritis—expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. The Journal of Pathology 193: 110–116.PubMedCrossRef Chou, C.T., J.S. Yang, and M.R. Lee. 2001. Apoptosis in rheumatoid arthritis—expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. The Journal of Pathology 193: 110–116.PubMedCrossRef
11.
Zurück zum Zitat Bae, S.C., W.J. Jung, E.J. Lee, R. Yu, and M.K. Sung. 2009. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. Journal of the American College of Nutrition 28: 56–62.PubMed Bae, S.C., W.J. Jung, E.J. Lee, R. Yu, and M.K. Sung. 2009. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. Journal of the American College of Nutrition 28: 56–62.PubMed
12.
Zurück zum Zitat Jackson, J.K., T. Higo, W.L. Hunter, and H.M. Burt. 2006. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflammation Research 55: 168–175.PubMedCrossRef Jackson, J.K., T. Higo, W.L. Hunter, and H.M. Burt. 2006. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflammation Research 55: 168–175.PubMedCrossRef
13.
Zurück zum Zitat Sato, M., T. Miyazaki, F. Kambe, K. Maeda, and H. Seo. 1997. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. The Journal of Rheumatology 24: 1680–1684.PubMed Sato, M., T. Miyazaki, F. Kambe, K. Maeda, and H. Seo. 1997. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. The Journal of Rheumatology 24: 1680–1684.PubMed
14.
Zurück zum Zitat Choi, E.J., S.C. Bae, R. Yu, J. Youn, and M.K. Sung. 2009. Dietary vitamin E and quercetin modulate inflammatory responses of collagen-induced arthritis in mice. Journal of Medicinal Food 12: 770–775.PubMedCrossRef Choi, E.J., S.C. Bae, R. Yu, J. Youn, and M.K. Sung. 2009. Dietary vitamin E and quercetin modulate inflammatory responses of collagen-induced arthritis in mice. Journal of Medicinal Food 12: 770–775.PubMedCrossRef
15.
Zurück zum Zitat Sung, M.S., E.G. Lee, H.S. Jeon, H.J. Chae, S.J. Park, Y.C. Lee, and W.H. Yoo. 2012. Quercetin inhibits IL-1β-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast. Inflammation 35: 1585–1594.PubMedCrossRef Sung, M.S., E.G. Lee, H.S. Jeon, H.J. Chae, S.J. Park, Y.C. Lee, and W.H. Yoo. 2012. Quercetin inhibits IL-1β-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast. Inflammation 35: 1585–1594.PubMedCrossRef
16.
Zurück zum Zitat Ong, C.S., E. Tran, T.T. Nguyen, C.K. Ong, S.K. Lee, J.J. Lee, C.P. Ng, C. Leong, and H. Huynh. 2004. Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncology Reports 11: 727–733.PubMed Ong, C.S., E. Tran, T.T. Nguyen, C.K. Ong, S.K. Lee, J.J. Lee, C.P. Ng, C. Leong, and H. Huynh. 2004. Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncology Reports 11: 727–733.PubMed
17.
Zurück zum Zitat Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.PubMedCrossRef Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.PubMedCrossRef
18.
Zurück zum Zitat Brunelle, J.K., and A. Letai. 2009. Control of mitochondrial apoptosis by the Bcl-2 family. Journal of Cell Science 122: 437–441.PubMedCrossRef Brunelle, J.K., and A. Letai. 2009. Control of mitochondrial apoptosis by the Bcl-2 family. Journal of Cell Science 122: 437–441.PubMedCrossRef
19.
Zurück zum Zitat Vaseva, A.V., and U.M. Moll. 2009. The mitochondrial p53 pathway. Biochimica et Biophysica Acta 1787: 414–420.PubMedCrossRef Vaseva, A.V., and U.M. Moll. 2009. The mitochondrial p53 pathway. Biochimica et Biophysica Acta 1787: 414–420.PubMedCrossRef
20.
Zurück zum Zitat Zhao, H., F. Traganos, and Z. Darzynkiewicz. 2008. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation. Cell Cycle 7: 3048–3055.PubMedCrossRef Zhao, H., F. Traganos, and Z. Darzynkiewicz. 2008. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation. Cell Cycle 7: 3048–3055.PubMedCrossRef
21.
Zurück zum Zitat Natarajan, V., N. Krithica, B. Madhan, and P.K. Sehgal. 2011. Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis. Journal of Pharmaceutical Sciences 100: 195–205.PubMedCrossRef Natarajan, V., N. Krithica, B. Madhan, and P.K. Sehgal. 2011. Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis. Journal of Pharmaceutical Sciences 100: 195–205.PubMedCrossRef
22.
Zurück zum Zitat Choi, J.A., J.Y. Kim, J.Y. Lee, C.M. Kang, H.J. Kwon, Y.D. Yoo, T.W. Kim, Y.S. Lee, and S.J. Lee. 2001. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. International Journal of Oncology 19: 837–844.PubMed Choi, J.A., J.Y. Kim, J.Y. Lee, C.M. Kang, H.J. Kwon, Y.D. Yoo, T.W. Kim, Y.S. Lee, and S.J. Lee. 2001. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. International Journal of Oncology 19: 837–844.PubMed
23.
Zurück zum Zitat Lee, T.J., O.H. Kim, Y.H. Kim, J.H. Lim, S. Kim, J.W. Park, and T.K. Kwon. 2006. Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Letters 240: 234–242.PubMedCrossRef Lee, T.J., O.H. Kim, Y.H. Kim, J.H. Lim, S. Kim, J.W. Park, and T.K. Kwon. 2006. Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Letters 240: 234–242.PubMedCrossRef
24.
Zurück zum Zitat Jacquemin, G., V. Granci, A.S. Gallouet, N. Lalaoui, A. Morlé, E. Iessi, A. Morizot, C. Garrido, T. Guillaudeux, and O. Micheau. 2012. Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin’s lymphoma B cells. Haematologica 97: 38–46.PubMedCrossRef Jacquemin, G., V. Granci, A.S. Gallouet, N. Lalaoui, A. Morlé, E. Iessi, A. Morizot, C. Garrido, T. Guillaudeux, and O. Micheau. 2012. Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin’s lymphoma B cells. Haematologica 97: 38–46.PubMedCrossRef
25.
Zurück zum Zitat Firestein, G.S., K. Nguyen, K.R. Aupperle, M. Yeo, D.L. Boyle, and N.J. Zvaifler. 1996. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. The American Journal of Pathology 149: 2143–2151.PubMed Firestein, G.S., K. Nguyen, K.R. Aupperle, M. Yeo, D.L. Boyle, and N.J. Zvaifler. 1996. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. The American Journal of Pathology 149: 2143–2151.PubMed
26.
Zurück zum Zitat Redondo, A., N. Estrella, A.G. Lorenzo, M. Cruzado, and C. Castro. 2012. Quercetin and catechin synergistically inhibit angiotensin II-induced redox-dependent signalling pathways in vascular smooth muscle cells from hypertensive rats. Free Radical Research 46: 619–627.PubMedCrossRef Redondo, A., N. Estrella, A.G. Lorenzo, M. Cruzado, and C. Castro. 2012. Quercetin and catechin synergistically inhibit angiotensin II-induced redox-dependent signalling pathways in vascular smooth muscle cells from hypertensive rats. Free Radical Research 46: 619–627.PubMedCrossRef
27.
Zurück zum Zitat Hwang, S.J., B. Choi, S.S. Kang, J.H. Chang, Y.G. Kim, Y.H. Chung, D.H. Sohn, M.W. So, C.K. Lee, W.H. Robinson, and E.J. Chang. 2012. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Research & Therapy 14: R14.CrossRef Hwang, S.J., B. Choi, S.S. Kang, J.H. Chang, Y.G. Kim, Y.H. Chung, D.H. Sohn, M.W. So, C.K. Lee, W.H. Robinson, and E.J. Chang. 2012. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Research & Therapy 14: R14.CrossRef
28.
Zurück zum Zitat Lau, S.T., Z.X. Lin, and P.S. Leung. 2010. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells. British Journal of Cancer 102: 583–593.PubMedCrossRef Lau, S.T., Z.X. Lin, and P.S. Leung. 2010. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells. British Journal of Cancer 102: 583–593.PubMedCrossRef
Metadaten
Titel
p53 Contributes to Quercetin-Induced Apoptosis in Human Rheumatoid Arthritis Fibroblast-like Synoviocytes
Publikationsdatum
01.04.2013
Erschienen in
Inflammation / Ausgabe 2/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9543-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.